Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Radiculitis

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44336   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    5 result(s) found for: Radiculitis. Displaying page 1 of 1.
    EudraCT Number: 2010-023962-39 Sponsor Protocol Number: 1014802/201 Start Date*: 2011-03-09
    Sponsor Name:Convergence Pharmaceuticals Ltd
    Full Title: A randomized, double blind, cross-over study to evaluate the safety and efficacy of CNV1014802 in subjects with neuropathic pain from lumbosacral radiculopathy
    Medical condition: Neuropathic pain from lumbosacral radiculopathy
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029205 - Nervous system disorders 10050219 Lumbar radiculopathy PT
    14.1 10029205 - Nervous system disorders 10054095 Neuropathic pain LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Completed) CZ (Completed) DK (Completed)
    Trial results: View results
    EudraCT Number: 2004-002948-10 Sponsor Protocol Number: A0081007 Start Date*: 2005-07-14
    Sponsor Name:Pfizer AB
    Full Title: A Randomised Placebo-Controlled Trial of the Efficacy and Safety of Pregabalin in the Treatment of Subjects with Neuropathic Pain Associated with Lumbo-sacral Radiculopathy (protocol dates 2004-11...
    Medical condition: Pain associated with lumbo-sacral radiculopathy
    Disease: Version SOC Term Classification Code Term Level
    7.0 10050085 VTc
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed) DE (Completed) IT (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2015-004775-78 Sponsor Protocol Number: 1014802-203 Start Date*: 2016-05-09
    Sponsor Name:Biogen Idec Research Limited
    Full Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of BIIB074 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy
    Medical condition: Neuropathic Pain From Lumbosacral Radiculopathy
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000014315 10054095 Neuropathic pain LLT
    20.0 10029205 - Nervous system disorders 10050219 Lumbar radiculopathy PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LV (Completed) GB (Completed) CZ (Completed) SK (Completed) AT (Completed) ES (Completed) NL (Completed) BE (Completed) FR (Completed) RO (Completed) BG (Completed) LT (Prematurely Ended) IT (Completed)
    Trial results: View results
    EudraCT Number: 2015-004796-68 Sponsor Protocol Number: 1014802-204 Start Date*: 2016-10-26
    Sponsor Name:Biogen Idec Research Limited
    Full Title: An Uncontrolled, Open-Label Extension Study to Evaluate the Long Term Safety, Tolerability, and Maintenance of Effect of BIIB074 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy
    Medical condition: Neuropathic Pain From Lumbosacral Radiculopathy
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000014315 10054095 Neuropathic pain LLT
    20.0 10029205 - Nervous system disorders 10050219 Lumbar radiculopathy PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LV (Completed) GB (Completed) SK (Completed) AT (Completed) ES (Completed) CZ (Completed) BG (Completed) BE (Completed) NL (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2021-006503-15 Sponsor Protocol Number: STA-LDH01 Start Date*: 2023-02-23
    Sponsor Name:Stayble Therapeutics
    Full Title: A prospective, randomised, double-blinded, placebo-controlled study investigating the safety and tolerability of STA363 in patients with radiculopathy caused by lumbar disc herniation
    Medical condition: Radiculopathy due to lumbar intervertebral disc herniation
    Disease: Version SOC Term Classification Code Term Level
    20.0 10029205 - Nervous system disorders 10029205 Nervous system disorders SOC
    20.0 10029205 - Nervous system disorders 10050219 Lumbar radiculopathy PT
    20.0 10029205 - Nervous system disorders 10052772 Lumbar spinal cord and nerve root disorders HLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: PL (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat May 17 13:43:18 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA